• Issue

    Cancer Communications: Volume 42, Issue 9

    799-905
    September 2022
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

ISSUE INFORMATION

Open Access

Issue Information

  • Pages: 799-800
  • First Published: 08 September 2022

EDITORIAL

Open Access

Nasopharyngeal carcinoma treatment paradigm after HK0501 – a potential way forward

Sharon S Poh,  Joseph TS Wee, 
  • Pages: 801-803
  • First Published: 01 August 2022

REVIEW

Open Access

Antibody variable region engineering for improving cancer immunotherapy

Hantao Lou,  Xuetao Cao, 
  • Pages: 804-827
  • First Published: 13 July 2022

ORIGINAL ARTICLES

Open Access

KRAS-G12D mutation drives immune suppression and the primary resistance of anti-PD-1/PD-L1 immunotherapy in non-small cell lung cancer

Chengming Liu,  Sufei Zheng,  Zhanyu Wang,  Sihui Wang,  Xinfeng Wang,  Lu Yang,  Haiyan Xu,  Zheng Cao,  Xiaoli Feng,  Qi Xue,  Yan Wang,  Nan Sun,  Jie He, 
  • Pages: 828-847
  • First Published: 11 July 2022
Open Access

PTPRO represses colorectal cancer tumorigenesis and progression by reprogramming fatty acid metabolism

Weixing Dai,  Wenqiang Xiang,  Lingyu Han,  Zixu Yuan,  Renjie Wang,  Yanlei Ma,  Yongzhi Yang,  Sanjun Cai,  Ye Xu,  Shaobo Mo,  Qingguo Li,  Guoxiang Cai, 
  • Pages: 848-867
  • First Published: 29 July 2022
Open Access

The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression

Ye Yuan,  Li-Hong Wang,  Xian-Xian Zhao,  Jiao Wang,  Meng-Si Zhang,  Qing-Hua Ma,  Sen Wei,  Ze-Xuan Yan,  Yue Cheng,  Xiao-Qing Chen,  Hong-Bo Zou,  Jia Ge,  Yan Wang,  Xia Zhang,  You-Hong Cui,  Tao Luo,  Xiu-Wu Bian, 
  • Pages: 868-886
  • First Published: 18 July 2022

LETTERS TO THE EDITOR

Open Access

Transcriptome-wide association analysis identified candidate susceptibility genes for nasopharyngeal carcinoma

Yong-Qiao He,  Wen-Qiong Xue,  Dan-Hua Li,  Tong-Min Wang,  Zhi-Ming Mai,  Da-Wei Yang,  Chang-Mi Deng,  Ying Liao,  Wen-Li Zhang,  Ruo-Wen Xiao,  Luting Luo,  Hua Diao,  Xiating Tong,  Yanxia Wu,  Jiang-Bo Zhang,  Ting Zhou,  Xi-Zhao Li,  Pei-Fen Zhang,  Xiao-Hui Zheng,  Shao-Dan Zhang,  Ye-Zhu Hu,  Minzhong Tang,  Yuming Zheng,  Yonglin Cai,  Ellen T. Chang,  Zhe Zhang,  Guangwu Huang,  Su-Mei Cao,  Qing Liu,  Lin Feng,  Ying Sun,  Maria Li Lung,  Hans-Olov Adami,  Weimin Ye,  Tai-Hing Lam,  Wei-Hua Jia, 
  • Pages: 887-891
  • First Published: 01 June 2022
Open Access

A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2

Emanuele Vitale,  Elisabetta Sauta,  Mila Gugnoni,  Federica Torricelli,  Veronica Manicardi,  Alessia Ciarrocchi, 
  • Pages: 892-896
  • First Published: 22 April 2022
Open Access

p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases

Pilar Fajardo,  Maria Taskova,  Miguel A. Martín-Serrano,  Jonas Hansen,  Sofie Slott,  Anna K. Jakobsen,  Marie-Louise Wibom,  Beñat Salegi,  Alberto Muñoz,  Antonio Barbachano,  Arpita Sharma,  John Mark Gubatan,  Aida Habtezion,  Juan J. Sanz-Ezquerro,  Kira Astakhova,  Ana Cuenda, 
  • Pages: 897-901
  • First Published: 07 July 2022
Open Access

Prediction of major adverse cardiac events is the first critical task in the management of immune checkpoint inhibitor-associated myocarditis

Yan Xu,  Yanjun Song,  Xiaoyan Liu,  Yuequan Shi,  Yingxian Liu,  Hao Qian,  Xiaoxing Gao,  Minjiang Chen,  Ruili Pan,  Jing Zhao,  Wei Zhong,  Wei Wu,  Mengzhao Wang, 
  • Pages: 902-905
  • First Published: 09 June 2022